Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Becton Dickinson and Co BDX

Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, and others. The Company's BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a wide range of settings. The BD Medical segment consists of various business units, including medication delivery solutions, medication management solutions, and pharmaceutical systems. The Company's BD Life Sciences segment provides products for the collection and transport of diagnostics specimens, and instruments and reagent systems to detect a broad range of infectious diseases, healthcare-associated infections and cancers. The Company's BD Interventional segment provides vascular, urology, oncology and surgical specialty products.


NYSE:BDX - Post by User

Post by johnson021on Sep 12, 2022 1:27am
235 Views
Post# 34955749

Anesthesia Endotracheal Tubes Market Trends Report 2022-27

Anesthesia Endotracheal Tubes Market Trends Report 2022-27

According to the latest report by IMARC Group, titled “Anesthesia Endotracheal Tubes Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027,” Offers a comprehensive analysis of the industry, which comprises insights on anesthesia endotracheal tubes market share.

The global anesthesia endotracheal tubes market reached a value of US$ 162.79Million in 2021. Anesthesia endotracheal tubes (ETTs) refer to the flexible catheters that are implanted in the trachea to administer anesthesia and maintain the airway passage of lungs in patients who are unconscious or unable to breathe on their own. These tubes also assist in preventing the aspiration of secretions into the lungs while allowing mechanical ventilation to help prevent suffocation. They can either be inserted through the mouth or rooted through the nose into the trachea for anesthesia management. Made from polyvinylchloride (PVC), they are single-use catheters that find extensive applications across the healthcare sector, especially in hospitals and clinics.

Global Anesthesia Endotracheal Tubes Market Trends:

The market is primarily driven by the increasing incidences of chronic respiratory disorders on the global level. Medical surgeries related to numerous pulmonary diseases, including pulmonary embolism, chronic obstructive pulmonary disorders (COPD) and sleep disorders, require the need for anesthesia endotracheal tubes for maintaining an open airway in patients. Coupled with the rising geriatric population across the globe, this is providing a thrust to the market growth. Along with this, the growing incidences of road accidents and the escalating number of trauma cases are also impelling the demand for these tubes. The market is further driven by the rapid outbreak of the novel coronavirus disease (COVID-19) and the growing number of patients who require critical medical care. Moreover, several industry players are continually engaging in the development of innovative product variants that offer enhanced comfort and convenience to the users. They are launching endotracheal tubes with flexible tips that are expected to navigate through fragile airways with minimal discomfort. Looking forward, IMARC Group expects the market to reach US$ 227.31Million by 2027, exhibiting a CAGR of 5.83% during 2022-2027.

Request Free Sample Report: https://www.imarcgroup.com/anesthesia-endotracheal-tubes-market/requestsample

Global Anesthesia Endotracheal Tubes Market 2022-2027 Analysis and Segmentation:

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

C.R. Bard Inc. (Becton, Dickinson and Company), ConvaTec Group Plc, Fuji Systems Co. Ltd., GE Healthcare Inc. (General Electric Company), Intersurgical Limited, Medtronic Plc, Neurovision Medical Products Inc., Sewoon Medical Co. Ltd., Smiths Medical Inc. and Teleflex Incorporated.

The report has segmented the market on the basis of Type, Thickness, Production Process, Application and Region.

Breakup by Intubation Type:

Nasotracheal

Orotracheal

Hybrid

Breakup by Product Type:

Regular Tubes

Reinforced/Armored Tubes

Coated Tubes

Others

Breakup by End User:

Hospitals

Ambulatory Surgery Centers

Others

Breakup by Region:

North America

Asia Pacific

Europe

Latin America

Middle East and Africa

Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/anesthesia-endotracheal-tubes-market

As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Competitive landscape, etc. Click request free sample report, the report will be delivered to you in PDF format via email within 24 to 48 hours after the payment confirmation.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us

IMARC Group

30 N Gould St Ste R

Sheridan, WY 82801 USA

Email: Sales@imarcgroup.com

Tel No:(D) +91 120 433 0800 |

Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

<< Previous
Bullboard Posts